PM3 USE OF PHARMACOGENETIC TESTING TO DETERMINE ADJUVANT HORMONAL THERAPY CHOICE IN EARLY STAGE BREAST CANCER PATIENTS- A VALUE OF INFORMATION ANALYSIS

May 1, 2009, 00:00 AM
10.1016/S1098-3015(10)73082-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)73082-5/fulltext
Section Title :
Section Order : 679
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73082-5&doi=10.1016/S1098-3015(10)73082-5
HEOR Topics :
Tags :
Regions :